Michael d'Emden Australian Diabetes Society and the Australian Diabetes Educators Association Annual Scientific Meeting 2016

Abstracts this author is presenting:

• Effect of Empagliflozin on Cardiovascular Death in Subgroups by Age: Results from EMPA-REG OUTCOME — ADS Clinical Orals - Type 2 Therapies
• Effect of Empagliflozin on Nephropathy in Subgroups by Age: Results from EMPA-REG OUTCOME — ADS Clinical Orals - Renal & Foot Complications
• Switching from twice-daily basal insulin to once-daily new insulin glargine 300 U/mL (Gla-300): an analysis in people with T2DM (EDITION 1 and 2) — ADS Clinical Poster Session - Therapy of type 2 diabetes
• Evaluation of fasting blood glucose as an initial diagnostic test for gestational diabetes mellitus (GDM). — ADS Clinical Orals - Pregnancy, diet & exercise